BioRestorative Therapies, Inc.
NASDAQ: BRTX0.00 n/a
+0.00%(+0.00)
Key facts
- Exchange
- NASDAQ Capital Market
- Sector
- Healthcare
- Industry
- Biotechnology
- CEO
- Lance Alstodt
- Employees
- 11
- Headquarters
- Melville, United States
- IPO year
- 2012
- Market cap
- $3.6M
- Website
- https://www.biorestorative.com
Loading BRTX…
Loading profile data…Frequently asked questions about BRTX
What does BioRestorative Therapies, Inc. (BRTX) do?
BioRestorative Therapies, Inc. is a life sciences company dedicated to developing regenerative medicine products and therapies. Their approach primarily utilizes adult stem cell protocols to address two key areas: disc/spine disease and metabolic disorders. Within their disc/spine program, known as brtxDisc, the company's leading cell therapy ca...
Where does BRTX trade?
BioRestorative Therapies, Inc. (BRTX) trades on the NASDAQ Capital Market.
What sector is BRTX in?
BioRestorative Therapies, Inc. (BRTX) operates in the Healthcare sector, specifically in the Biotechnology industry.
Who is the CEO of BioRestorative Therapies, Inc.?
Lance Alstodt is the chief executive officer of BioRestorative Therapies, Inc. (BRTX).
Where is BioRestorative Therapies, Inc. headquartered?
BioRestorative Therapies, Inc. is headquartered in United States.
Does BRTX pay a dividend?
BioRestorative Therapies, Inc. (BRTX) does not currently pay a regular dividend. Check the dividends tab for any historical or special distributions.
When did BRTX go public?
BioRestorative Therapies, Inc. (BRTX) completed its initial public offering in 2012.